ProfileGDS4718 / 200782_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 93% 98% 94% 95% 99% 98% 94% 96% 95% 95% 94% 96% 97% 96% 99% 96% 98% 97% 98% 95% 96% 95% 97% 97% 97% 94% 97% 93% 97% 95% 98% 93% 92% 98% 98% 95% 98% 93% 99% 92% 97% 99% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.164794
GSM549102patient 115, normal, homogenized [OPG study]9.8175693
GSM549104patient 119, normal, homogenized [OPG study]11.580998
GSM549108patient 138, normal, homogenized [OPG study]9.9051994
GSM549119patient 077, normal, homogenized [OPG study]10.366395
GSM549133patient 032, cancer, homogenized [OPG study]11.896199
GSM549139patient 042, cancer, homogenized [OPG study]11.304698
GSM549099patient 107, normal, homogenized [OPG study]9.934394
GSM549109patient 139, normal, homogenized [OPG study]10.54496
GSM549110patient 046, normal, homogenized [OPG study]10.470495
GSM549114patient 063, normal, homogenized [OPG study]10.424195
GSM549122patient 082, normal, homogenized [OPG study]9.9970694
GSM549134patient 033, cancer, homogenized [OPG study]10.626996
GSM549136patient 036, cancer, homogenized [OPG study]10.88397
GSM549140patient 044, cancer, homogenized [OPG study]10.647796
GSM549111patient 047, normal, homogenized [OPG study]12.115699
GSM549113patient 057, normal, homogenized [OPG study]10.781896
GSM549132patient 031, cancer, homogenized [OPG study]11.234598
GSM549137patient 038, cancer, homogenized [OPG study]10.768397
GSM549142patient 047, cancer, homogenized [OPG study]11.181198
GSM549100patient 110, normal, homogenized [OPG study]10.348595
GSM549107patient 135, normal, homogenized [OPG study]10.576696
GSM549115patient 068, normal, homogenized [OPG study]10.518595
GSM549116patient 072, normal, homogenized [OPG study]11.131897
GSM549120patient 078, normal, homogenized [OPG study]10.838697
GSM549131patient 030, cancer, homogenized [OPG study]10.78297
GSM549118patient 074, normal, homogenized [OPG study]10.174694
GSM549129patient 027, cancer, homogenized [OPG study]10.487597
GSM549123patient 088, normal, homogenized [OPG study]9.7851593
GSM549124patient 006, cancer, homogenized [OPG study]10.664497
GSM549126patient 015, cancer, homogenized [OPG study]10.166795
GSM549128patient 025, cancer, homogenized [OPG study]11.635298
GSM549103patient 117, normal, homogenized [OPG study]9.7599793
GSM549117patient 073, normal, homogenized [OPG study]9.7427792
GSM549138patient 041, cancer, homogenized [OPG study]11.40298
GSM549141patient 045, cancer, homogenized [OPG study]11.706998
GSM549130patient 028, cancer, homogenized [OPG study]10.147395
GSM549101patient 111, normal, homogenized [OPG study]11.115998
GSM549105patient 128, normal, homogenized [OPG study]9.7220893
GSM549106patient 134, normal, homogenized [OPG study]12.32699
GSM549112patient 048, normal, homogenized [OPG study]9.6743592
GSM549125patient 011, cancer, homogenized [OPG study]10.786697
GSM549127patient 024, cancer, homogenized [OPG study]12.406599
GSM549135patient 035, cancer, homogenized [OPG study]11.144998